• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rheumatic diseases in intensive care unit patients with COVID-19.

作者信息

Moiseev Sergey, Avdeev Sergey, Brovko Michail, Yavorovskiy Andrey, Novikov Pavel I, Umbetova Karina, Akulkina Larisa, Tsareva Natal'ya, Fomin Victor

机构信息

Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation

Clinic of Pulmonology, Sechenov First Moscow State Medical University, Moscow, Russian Federation.

出版信息

Ann Rheum Dis. 2021 Feb;80(2):e16. doi: 10.1136/annrheumdis-2020-217676. Epub 2020 May 20.

DOI:10.1136/annrheumdis-2020-217676
PMID:32434823
Abstract
摘要

相似文献

1
Rheumatic diseases in intensive care unit patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症监护病房患者的风湿性疾病
Ann Rheum Dis. 2021 Feb;80(2):e16. doi: 10.1136/annrheumdis-2020-217676. Epub 2020 May 20.
2
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.COVID-19 与风湿性自身免疫性系统性疾病：一项大型意大利患者系列报告。
Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27.
3
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.COVID-19 住院患者合并慢性炎症和自身免疫性风湿性疾病的临床结局：一项多中心匹配队列研究。
Ann Rheum Dis. 2020 Dec;79(12):1544-1549. doi: 10.1136/annrheumdis-2020-218296. Epub 2020 Aug 12.
4
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.沙特阿拉伯东部省份风湿性疾病患者的 COVID-19 。
J Med Life. 2023 Jun;16(6):873-882. doi: 10.25122/jml-2023-0037.
5
What is the true incidence of COVID-19 in patients with rheumatic diseases?风湿性疾病患者中新型冠状病毒肺炎的真实发病率是多少？
Ann Rheum Dis. 2021 Feb;80(2):e18. doi: 10.1136/annrheumdis-2020-217615. Epub 2020 Apr 22.
6
Prevalence of rheumatic disease.风湿性疾病的患病率。
JAMA. 1973 Apr 30;224(5 Suppl):679-80.
7
Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study.在一项全国性队列研究中，与2016 - 2019年相比，2020 - 2023年期间炎性关节炎、系统性红斑狼疮和系统性硬化症的患病率有所上升。
Rheumatol Int. 2024 Dec;44(12):2837-2846. doi: 10.1007/s00296-024-05733-y. Epub 2024 Oct 8.
8
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.COVID-19 相关住院风险因素在自身免疫性炎症性风湿病患者中的分析。
Ann Rheum Dis. 2020 Nov;79(11):1393-1399. doi: 10.1136/annrheumdis-2020-217984. Epub 2020 Aug 7.
9
Epidemiology of the rheumatic diseases.风湿性疾病的流行病学
Nurs Clin North Am. 1984 Dec;19(4):713-25.
10
Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.在 COVID-19 大流行期间，炎症性风湿病患者的自我保护策略和健康行为：丹麦 DANBIO 注册中心随访的 12000 多名炎症性风湿病患者的结果和预测因素。
RMD Open. 2021 Jan;7(1). doi: 10.1136/rmdopen-2020-001505.

引用本文的文献

1
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.新冠疫情及疫苗接种运动对大流行头三年中1755例系统性硬化症患者的影响。在下一疫情阶段，免疫反应受损者、正在接受免疫调节治疗者以及患有疾病相关肺部病变者面临的潜在风险。
J Transl Autoimmun. 2023 Oct 9;7:100212. doi: 10.1016/j.jtauto.2023.100212. eCollection 2023 Dec.
2
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.沙特阿拉伯东部省份风湿性疾病患者的 COVID-19 。
J Med Life. 2023 Jun;16(6):873-882. doi: 10.25122/jml-2023-0037.
3
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases.COVID-19 症状和治疗在自身免疫性疾病中的全面综述。
Virol J. 2023 Jan 7;20(1):1. doi: 10.1186/s12985-023-01967-7.
4
Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses.糖尿病与风湿性疾病在 COVID-19 大流行期间的相互作用：对感染风险、结局和免疫反应的影响。
Clin Rheumatol. 2022 Dec;41(12):3897-3913. doi: 10.1007/s10067-022-06365-y. Epub 2022 Sep 9.
5
Systemic sclerosis in the time of COVID-19.新冠疫情时期的系统性硬化症
Lancet Rheumatol. 2022 Aug;4(8):e566-e575. doi: 10.1016/S2665-9913(22)00130-8. Epub 2022 Jul 21.
6
COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic.2019冠状病毒病与系统性硬化症：应对大流行的挑战
J Scleroderma Relat Disord. 2021 Feb;6(1):58-65. doi: 10.1177/2397198320963393. Epub 2020 Oct 18.
7
Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.自身免疫性疾病和新冠肺炎作为不良预后的风险因素：来自西班牙全国性SEMI-COVID-19登记处的13940例住院患者数据
J Clin Med. 2021 Apr 23;10(9):1844. doi: 10.3390/jcm10091844.
8
COVID-19, rheumatic diseases and immune dysregulation-a perspective.COVID-19 与风湿性疾病和免疫失调：一个观察视角。
Clin Rheumatol. 2021 Feb;40(2):433-442. doi: 10.1007/s10067-020-05529-y. Epub 2021 Jan 7.
9
Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.在 COVID-19 大流行期间，炎症性风湿病患者的自我保护策略和健康行为：丹麦 DANBIO 注册中心随访的 12000 多名炎症性风湿病患者的结果和预测因素。
RMD Open. 2021 Jan;7(1). doi: 10.1136/rmdopen-2020-001505.
10
COVID-19 in Italian Sjögren's syndrome patients: a monocentric study.意大利干燥综合征患者中的新型冠状病毒肺炎：一项单中心研究。
Rheumatol Int. 2021 Jan;41(1):235-236. doi: 10.1007/s00296-020-04722-1. Epub 2020 Oct 18.